GlobeNews Wire

Lightrun Runtime Context Empowers AI Coding Agents to Build Software That Works in the Real World

NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Lightrun, a leader in software reliability, today launched its new Model Context…

1 month ago

Acquia Releases Next Generation SaaS CMS with Built-In AI Agents

New agents automate content creation, optimization, and governance, establishing brands as the authoritative source for AI answer engines. December 10,…

1 month ago

Genius Group Executes Fourth Buyback of One Million Shares

SINGAPORE, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading…

1 month ago

Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference

EDEN PRAIRIE, Minn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading…

1 month ago

JASCAYD (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five…

1 month ago

Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility

December 10, 2025 04:00 ET  | Source: Igyxos TOURS, France, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology…

1 month ago

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced…

1 month ago

Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning

SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on…

1 month ago

Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University

- First patient in the world treated with Alpha DaRT® in the brain – - According to the National Brain…

1 month ago

Digital Culture Group Dominates Awards Season With Wins in AI Innovation

Adweek Tech Stack Awards Recognize DCG’s ARI-Driven Success with Edmond’s Honor Bourbon DCG’s ARI Platform Wins Best AI Tool at…

1 month ago